» Articles » PMID: 34754152

Evaluation of Botanicals As Potential COVID-19 Symptoms Terminator

Overview
Specialty Gastroenterology
Date 2021 Nov 10
PMID 34754152
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Information about the coronavirus disease 2019 (COVID-19) pandemic is still evolving since its appearance in December 2019 and has affected the whole world. Particularly, a search for an effective and safe treatment for COVID-19 continues. Botanical mixtures contain secondary metabolites (such as flavonoids, phenolics, alkaloids, essential oils ) with many therapeutic effects. In this study, the use of herbal treatments against COVID-19 was evaluated. Medical synthetic drugs focus mainly on respiratory symptoms, however herbal therapy with plant extracts may be useful to relieve overall symptoms of COVID-19 due to the variety of bioactive ingredients. Since COVID-19 is a virus that affects the respiratory tract, the antiviral effects of botanicals/plants against respiratory viruses have been examined through clinical studies. Data about COVID-19 patients revealed that the virus not only affects the respiratory system but different organs including the gastrointestinal (GI) system. As GI symptoms seriously affect quality of life, herbal options that might eliminate these problems were also evaluated. Finally, computer modeling studies of plants and their active compounds on COVID-19 were included. In summary, herbal therapies were identified as potential options for both antiviral effects and control of COVID-19 symptoms. Further data will be needed to enlighten all aspects of COVID-19 pathogenesis, before determining the effects of plants on severe acute respiratory syndrome coronavirus 2.

Citing Articles

Fermented and as Perspective Food Supplements for the Treatment of Post-COVID Symptoms: Randomized Placebo-Controlled Clinical Laboratory Study.

Kharaeva Z, Shokarova A, Shomakhova Z, Ibragimova G, Trakhtman P, Trakhtman I Nutrients. 2022; 14(11).

PMID: 35684003 PMC: 9182401. DOI: 10.3390/nu14112203.

References
1.
Tiralongo E, Lea R, Wee S, Hanna M, Griffiths L . Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers. Evid Based Complement Alternat Med. 2012; 2012:417267. PMC: 3249603. DOI: 10.1155/2012/417267. View

2.
Jawad M, Schoop R, Suter A, Klein P, Eccles R . Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med. 2012; 2012:841315. PMC: 3457740. DOI: 10.1155/2012/841315. View

3.
Chang J, Wang K, Yeh C, Shieh D, Chiang L . Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J Ethnopharmacol. 2012; 145(1):146-51. DOI: 10.1016/j.jep.2012.10.043. View

4.
Salve J, Pate S, Debnath K, Langade D . Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. 2020; 11(12):e6466. PMC: 6979308. DOI: 10.7759/cureus.6466. View

5.
Patel C, Goswami D, Jaiswal D, Parmar R, Solanki H, Pandya H . Pinpointing the potential hits for hindering interaction of SARS-CoV-2 S-protein with ACE2 from the pool of antiviral phytochemicals utilizing molecular docking and molecular dynamics (MD) simulations. J Mol Graph Model. 2021; 105:107874. PMC: 7897937. DOI: 10.1016/j.jmgm.2021.107874. View